JESSICA AGUILLON: Open Payments
NPI 1053862177 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 34 payments from 15 companies in 2025. Trend: 2023 $564 · 2024 $412 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $312 |
| ABBVIE INC. | 3 | $88 |
| Ferring Pharmaceuticals Inc. | 3 | $66 |
| Procept Biorobotics Corporation | 1 | $63 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $55 |
| TOLMAR, INC. | 2 | $51 |
| Dendreon Pharmaceuticals LLC | 2 | $50 |
| COLOPLAST CORP | 2 | $38 |
| UROGEN PHARMA, INC. | 2 | $35 |
| ABC Home Medical Supply, Inc. | 1 | $35 |
Products named: GEMTESA, BOTOX, ADSTILADRIN, AQUABEAM ROBOTIC SYSTEM, JOURNAVX, JATENZO, PROVENGE, Exparel.
Industry payments across TX — which companies pay providers there.
